Tandem Diabetes Care TNDM reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Tandem Diabetes Care their estimated earnings by 50.0%, reporting an EPS of $0.09 versus an estimate of $0.06, which surprised analysts.
Revenue was up $56,024,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14, which was followed by a 4.73% increase in the share price the next day.
Here's a look at Tandem Diabetes Care's past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.16 | 0.12 | -0.10 |
| EPS Actual | 0.06 | -0.08 | 0.22 | -0.15 |
| Revenue Estimate | 143.63M | 121.96M | 141.58M | 115.15M |
| Revenue Actual | 172.14M | 141.04M | 168.06M | 123.60M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
